CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS

Influenza is a seasonal infectious disease widespread across the globe. In Russia the share of influenza and other acute respiratory viral infections account for up to 90% of all infectious diseases. Scientific and reasonable method of influenza prevention is vaccination. However, traditional curren...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I. B. Esmagambetov, S. V. Alekseeva, K. S. Sayadyan, M. M. Shmarov
Formato: article
Lenguaje:RU
Publicado: Sankt-Peterburg : NIIÈM imeni Pastera 2016
Materias:
Acceso en línea:https://doaj.org/article/cae30481594f424ea89cbd65c91b0c9b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cae30481594f424ea89cbd65c91b0c9b
record_format dspace
spelling oai:doaj.org-article:cae30481594f424ea89cbd65c91b0c9b2021-11-22T07:09:47ZCURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS2220-76192313-739810.15789/2220-7619-2016-2-117-132https://doaj.org/article/cae30481594f424ea89cbd65c91b0c9b2016-06-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/397https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Influenza is a seasonal infectious disease widespread across the globe. In Russia the share of influenza and other acute respiratory viral infections account for up to 90% of all infectious diseases. Scientific and reasonable method of influenza prevention is vaccination. However, traditional current influenza vaccines can’t induce protection against various virus strains that differ substantially in terms of their antigenic structure, and thus require periodic updates to its immunogenic components. In addition, there is the risk of a pandemic caused by an entirely new antigen in relation to variants of influenza virus A. Attempts to improve on traditional approaches to vaccination have focused primarily on improving production technologies and to increase immunogenicity of vaccines. Therefore, the urgent task is the creation of vaccines able to induce immune response a broad spectrum against different influenza virus strains and human strains of avian influenza, also can cause disease in humans. Protective effect of universal vaccine should be the induction of integrated immune response, based on the formulation of cross-reactive antibodies and T cells. The development of such universal vaccine could remove the need for periodical strain composition update of existing vaccines and, accor dingly, will be able to give the vaccine manufacturer itself, production planning regardless of epidemic seasons. Currently, the most widely studied antigens as key components of flu vaccines are proteins M2 and NP as well as the hemagglutinin of influenza virus. This review summarizes and lists some data of domestic and foreign research on a universal influenza virus vaccine.I. B. EsmagambetovS. V. AlekseevaK. S. SayadyanM. M. ShmarovSankt-Peterburg : NIIÈM imeni Pasteraarticleinfluenza virusuniversal vaccinehaemagglutininm2 (ion channel)nucleoproteinwide range immune responseInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 6, Iss 2, Pp 117-132 (2016)
institution DOAJ
collection DOAJ
language RU
topic influenza virus
universal vaccine
haemagglutinin
m2 (ion channel)
nucleoprotein
wide range immune response
Infectious and parasitic diseases
RC109-216
spellingShingle influenza virus
universal vaccine
haemagglutinin
m2 (ion channel)
nucleoprotein
wide range immune response
Infectious and parasitic diseases
RC109-216
I. B. Esmagambetov
S. V. Alekseeva
K. S. Sayadyan
M. M. Shmarov
CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
description Influenza is a seasonal infectious disease widespread across the globe. In Russia the share of influenza and other acute respiratory viral infections account for up to 90% of all infectious diseases. Scientific and reasonable method of influenza prevention is vaccination. However, traditional current influenza vaccines can’t induce protection against various virus strains that differ substantially in terms of their antigenic structure, and thus require periodic updates to its immunogenic components. In addition, there is the risk of a pandemic caused by an entirely new antigen in relation to variants of influenza virus A. Attempts to improve on traditional approaches to vaccination have focused primarily on improving production technologies and to increase immunogenicity of vaccines. Therefore, the urgent task is the creation of vaccines able to induce immune response a broad spectrum against different influenza virus strains and human strains of avian influenza, also can cause disease in humans. Protective effect of universal vaccine should be the induction of integrated immune response, based on the formulation of cross-reactive antibodies and T cells. The development of such universal vaccine could remove the need for periodical strain composition update of existing vaccines and, accor dingly, will be able to give the vaccine manufacturer itself, production planning regardless of epidemic seasons. Currently, the most widely studied antigens as key components of flu vaccines are proteins M2 and NP as well as the hemagglutinin of influenza virus. This review summarizes and lists some data of domestic and foreign research on a universal influenza virus vaccine.
format article
author I. B. Esmagambetov
S. V. Alekseeva
K. S. Sayadyan
M. M. Shmarov
author_facet I. B. Esmagambetov
S. V. Alekseeva
K. S. Sayadyan
M. M. Shmarov
author_sort I. B. Esmagambetov
title CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
title_short CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
title_full CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
title_fullStr CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
title_full_unstemmed CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
title_sort current approaches to universal vaccine against influenza virus
publisher Sankt-Peterburg : NIIÈM imeni Pastera
publishDate 2016
url https://doaj.org/article/cae30481594f424ea89cbd65c91b0c9b
work_keys_str_mv AT ibesmagambetov currentapproachestouniversalvaccineagainstinfluenzavirus
AT svalekseeva currentapproachestouniversalvaccineagainstinfluenzavirus
AT kssayadyan currentapproachestouniversalvaccineagainstinfluenzavirus
AT mmshmarov currentapproachestouniversalvaccineagainstinfluenzavirus
_version_ 1718418069719613440